Disease-Vaccine-Landing-Page

Contraindications to receiving the Prevnar 20 (PCV20) vaccine documented in Wyeth Pharmaceuticals package insert include persons who have experienced a severe allergic reaction or anaphylaxis to any component of PCV20...

Contraindications to receiving the Prevnar 13 (PCV13) vaccine documented in Wyeth Pharmaceuticals package insert include persons who have experienced a severe allergic reaction or anaphylaxis to any component of Prevnar...

As of December 27, 2024, there have been 28,316 serious adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) in connection with pneumococcal vaccinations (PCV7, PCV13, PCV15, PCV20,...

According to the PCV20 package insert, in pre-licensing clinical trials, the most commonly reported side effects following vaccination in children 15 months of age and younger who received four doses...

All pre-licensing clinical safety trials of PCV15 in adults compared the vaccine to PCV13. In clinical trials, common side effects reported following vaccination included injection site pain, redness, and swelling,...

According to the CDC, approximately 50 percent of individuals who receive the pneumococcal polysaccharide vaccine (PPSV23) experience pain and redness at the injection site. Muscle aches, fever, and more severe...

Adverse reactions following administration of PCV13 differed by dose in the series and age of the recipient. In children, the most commonly reported reactions included irritability, drowsiness, loss of appetite,...

The continued emergence of non-vaccine types pneumococcal strains prompted the development of new pneumococcal vaccines. Merck received FDA approval in July 2021 for a 15-valent pneumococcal vaccine, PCV15, for use...

Information on pneumococcal conjugate vaccine efficacy found in the Prevnar 13(PCV13) product insert reports information pertaining to the original PCV vaccine, Prevnar (PCV7). PCV7 was reported to be 100 percent...

The initial pre-licensing clinical trials of a pneumococcal capsular polysaccharide involved a comparison study of the effectiveness of a 6-valent polysaccharide vaccine against a 12-valent polysaccharide vaccine. The study involved...